Birmingham, UK | 29th November  2012


Isogenica, Cambridge UK and Aston University, Birmingham UK secure funding from the Technology Strategy Board, the UK’s innovation agency, for a £0.5M project to develop a gene library assembly technology exclusively licensed to Isogenica.

The funding enables Isogenica to develop a robust, automated manufacturing process for the commercial synthesis of ratio controlled gene libraries using a patent protected methodology invented by Dr Anna Hine and her team at Aston University.  The capability to build high quality libraries has application in antibody, protein scaffold and peptide discovery, where high integrity libraries can be designed and built that will increase library diversity and maximise the probability of finding good quality leads.


“Isogenica has been approached on a number of occasions by customers interested in accessing ratio controlled libraries and for screening libraries using our proprietary CIS Display technology.  We have an exclusive license to Aston University’s innovative technology and will develop the approach to meet the market needs for rapid, high quality gene libraries and we hope to launch this product area within the next 6 months”


said Kevin Mathews, CEO of Isogenica.


Notes to Editors

About Isogenica

Isogenica specialises in the discovery and optimisation of therapeutic and diagnostic peptides, proteins and antibodies using its proprietary technology, CIS display.  Founded in 2000, Isogenica has developed a unique capability in the field of protein engineering.  Isogenica’s CIS display technology is an in vitro display technology that allows the rapid generation of polypeptide and antibody libraries from which it is possible to select lead molecules with high affinity and specificity for most targets.


Aston University

Founded in 1895 and a University since 1966, Aston is a long established research-led University known for its world-class teaching quality and strong links to industry, government and commerce. Professor Dame Julia King became Vice-Chancellor of the University in 2006. Research in Aston’s School of Life & Health Sciences focuses on significantly extending our understanding of the processes of health and disease and the personal and social context in which they occur. Our goal is to apply the knowledge gained to clinical products, policy and practice.
About the Technology Strategy Board

The Technology Strategy Board is the UK’s innovation agency.  Its goal is to accelerate economic growth by stimulating and supporting business-led innovation.  Sponsored by the Department for Business, Innovation and Skills (BIS), the Technology Strategy Board brings together business, research and the public sector, supporting and accelerating the development of innovative products and services to meet market needs, tackle major societal challenges and help build the future economy. For more information please visit